Showing results (651-660 of 991) with videos related to
Sort By:
Pageof 100
Therapeutic Advances in Respiratory Disease|July 27, 2022
Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysisHana Müllerová, Jonathan Marshall, Enrico de Nigris, et al.Therapeutic Advances in Respiratory Disease|September 15, 2018
New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1Nicolas Villanueva, Lyudmila BazhenovaTherapeutic Advances in Respiratory Disease|August 23, 2018
What is the role of bronchial thermoplasty in the management of severe asthma?Aoife O'Reilly, Stephen LaneTherapeutic Advances in Respiratory Disease|September 30, 2021
Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategiesGiorgio Walter Canonica, Pierluigi Paggiaro, Francesco Blasi, et al.Therapeutic Advances in Respiratory Disease|September 30, 2021
A new protocol for exercise testing in COPD; improved prediction algorithm for W and validation of the endurance test in a placebo-controlled double bronchodilator studyEllen Tufvesson, Finn Radner, Anton Simonsen, et al.Therapeutic Advances in Respiratory Disease|October 19, 2012
The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary diseaseFrançois Maltais, Julie MilotTherapeutic Advances in Respiratory Disease|March 6, 2023
Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature reviewAyana Suzuki, Koichiro Kamio, Mitsuhiro Takeno, et al.Therapeutic Advances in Respiratory Disease|January 31, 2023
Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortalityKathrin Kahnert, Rudolf A Jörres, Hans-Ulrich Kauczor, et al.Therapeutic Advances in Respiratory Disease|February 12, 2026
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studiesArtur Bednarczyk, Magnus Aurivillius, Mandeep Jassal, et al.Therapeutic Advances in Respiratory Disease|February 24, 2025
A novel nomogram for predicting postoperative pneumonia risk in patients with localized bronchiectasisCai Yongsheng, Ke Lihui, Hao Xuefeng, et al.Pageof 100